Stock Fundamentals

Company Information

Company Name
Abeona Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US00289Y2063
CIK: 0000318306
CUSIP: 00431M308
Currency: USD
Full Time Employees: 226
Phone: 646 813 4701
Fiscal Year End: December
IPO Date: Sep 19, 1980
Description:

Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.

Address:

6555 Carnegie Avenue, Cleveland, OH, United States, 44103

Directors & Officers

Name Title Year Born
Dr. Vishwas Seshadri M.B.A., Ph.D. President, CEO & Director 1976
Mr. Joseph Walter Vazzano CPA Chief Financial Officer 1984
Dr. Brendan M. O'Malley J.D., Ph.D. Chief Legal Officer 1969
Mr. Brian Kevany Ph.D. Chief Technical & Scientific Officer NA
Mr. Gregory Gin Vice President of Investor Relations & Corporate Communications NA
Ms. Gianine Esposito Senior VP & Chief People Officer NA
Mr. Jon Voss VP & Head of Quality 1960
Dr. Madhav Vasanthavada M.B.A., Ph.D. SVP, Chief Commercial Officer & Head of Business Development 1979
Mr. Carl Denny Senior Vice President of Regulatory Affairs NA
Ms. Megan Callan Vice President & Head of Quality NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 02, 2026 Eric Crombez N/A Sale 16.28K $5.09 $82.89K
Feb 02, 2026 Leila Alland N/A Sale 18.07K $5.09 $91.95K
Feb 02, 2026 Mark Alvino N/A Sale 2.00K $5.09 $10.18K
Feb 02, 2026 Christine Berni Silverstein N/A Sale 20.07K $5.09 $102.16K
Jan 22, 2026 Brendan M O'malley N/A Sale 13.58K $5.33 $72.37K
Jan 22, 2026 Joseph Walter Vazzano N/A Sale 18.67K $5.33 $99.49K
Jan 22, 2026 Madhav Vasanthavada N/A Sale 12.61K $5.29 $66.71K
Jan 22, 2026 Vishwas Seshadri N/A Sale 69.83K $5.33 $372.20K
Jan 21, 2026 Mark Alvino N/A Sale 13.50K $5.23 $70.61K
Dec 29, 2025 Vishwas Seshadri N/A Sale 25.00K $5.31 $132.75K
Nov 13, 2025 Mark Alvino N/A Sale 15.00K $4.74 $71.10K
Oct 16, 2025 Vishwas Seshadri N/A Sale 249.00 $5.49 $1.37K
Sep 30, 2025 Vishwas Seshadri N/A Sale 25.00K $5.24 $131.00K
Sep 29, 2025 Joseph Walter Vazzano N/A Sale 9.04K $5.39 $48.70K
Sep 29, 2025 Vishwas Seshadri N/A Sale 19.27K $5.39 $103.89K
Sep 29, 2025 Brendan M O'malley N/A Sale 9.37K $5.39 $50.48K
Sep 22, 2025 Brendan M O'malley N/A Sale 688.00 $5.43 $3.74K
Jul 22, 2025 Joseph Walter Vazzano N/A Sale 1.50K $6.64 $9.97K
Jul 09, 2025 Brendan M O'malley N/A Sale 17.43K $5.86 $102.13K
Jul 09, 2025 Christine Berni Silverstein N/A Sale 13.09K $5.86 $76.72K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Nantahala Capital Management, LLC 5.01M Mar 31, 2026 8.81% $0.83 1.01%
BlackRock Inc 3.20M Mar 31, 2026 5.62% $0.00 1.13%
AIGH Capital Management, LLC 3.10M Mar 31, 2026 5.45% $1.89 55.00%
Vanguard Group Inc 2.76M Dec 31, 2025 4.85% $0.00 5.93%
Suvretta Capital Management, LLC 2.68M Mar 31, 2026 4.70% $0.31 0.00%
Cable Car Capital LLC 2.50M Dec 31, 2025 4.40% $0.44 316.67%
Kennedy Capital Management Inc 1.26M Mar 31, 2026 2.22% $0.12 20.32%
Geode Capital Management, LLC 1.21M Mar 31, 2026 2.13% $0.00 6.39%
The Goldman Sachs Group Inc 1.13M Mar 31, 2026 1.99% $0.00 125.14%
State Street Corp 957.33K Mar 31, 2026 1.68% $0.00 6.55%
NAN FUNG TRINITY (HK) Ltd 956.77K Mar 31, 2026 1.68% $0.47 0.00%
Propel Bio Management LLC 830.78K Dec 31, 2025 1.46% $3.74 -14.71%
Awm Investment Company Inc 803.13K Mar 31, 2026 1.41% $0.40 3.75%
683 Capital Management LLC 770.00K Mar 31, 2026 1.35% $0.18 0.00%
Stonepine Capital Management Llc 746.59K Mar 31, 2026 1.31% $1.34 5.23%
SILVERARC CAPITAL MANAGEMENT, LLC 648.94K Mar 31, 2026 1.14% $0.30 3.38%
J. Goldman & Co LP 640.53K Mar 31, 2026 1.13% $0.08 60.57%
Diametric Capital, LP 611.52K Mar 31, 2026 1.08% $0.71 -11.94%
Balyasny Asset Management LLC 589.85K Mar 31, 2026 1.04% $0.00 -0.32%
Citigroup Inc 522.45K Mar 31, 2026 0.92% $0.00 0.26%

Shares Statistics

Shares Outstanding: 57.00M
Shares Float: 36.34M
% Insiders: 1,672.40%
% Institutions: 7,053.60%
Short % Float: 27.25%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 1.53M 2.69% ▲ 0.00% Apr 30, 2026
2 iShares Russell 2000 ETF 1.11M 1.94% ▲ 0.85% Apr 30, 2026
3 Kennedy Micro Cap 874.59K 1.54% ▲ 20.64% Mar 31, 2026
4 Vanguard Institutional Extnd Mkt Idx Tr 581.19K 1.02% ▲ 0.00% Apr 30, 2026
5 Simplify Propel Opportunities ETF 500.34K 0.88% ▲ 0.00% Apr 30, 2026
6 Fidelity Small Cap Index 431.58K 0.76% ▲ 1.28% Feb 28, 2026
7 Kennedy Micro Cap Opportunities 387.03K 0.68% ▲ 19.93% Mar 31, 2026
8 iShares Russell 2000 Growth ETF 379.58K 0.67% ▲ 10.28% Apr 30, 2026
9 Russell 2000 Equity Index Fund B 283.89K 0.50% ▼ 0.05% Dec 31, 2025
10 Fidelity Extended Market Index 283.02K 0.50% ▲ 4.13% Mar 31, 2026

Valuation Metrics

Enterprise Value: $179.49M
Trailing P/E: 6.04
Forward P/E: 526.32

Financial Highlights

Market Cap: $327.15M
EBITDA: $-90.05M
P/E Ratio: $6.04
PEG Ratio: $0.00
Book Value: $2.55
Earnings/Share: $0.95
Profit Margin: 454.86%
Operating Margin: -264.14%
ROA (TTM): -38.92%
ROE (TTM): 70.99%
Revenue (TTM): $14.54M
Revenue/Share (TTM): $0.27
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -100.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 6.93x 0.13x 0.27x -23.92x -0.24x
2024-12-31 6.08x 0.45x 0.60x -15.26x -0.35x
2023-12-31 4.15x 0.07x 0.77x -112.76x -0.02x
2022-12-31 6.83x 0.07x 0.58x -69.18x -0.05x
2021-12-31 3.39x 0.04x 0.47x -24.57x -0.02x
2020-12-31 2.33x 0.03x 0.32x -19.79x -0.05x
2019-12-31 3.42x 0.01x 0.20x -192.73x -0.02x
2018-12-31 4.37x 0.22x 0.23x -5,287.82x -0.55x
2017-12-31 25.07x -0.02x 0.05x -3,479.50x 0.14x
2016-12-31 8.37x 0.00x 0.11x -3,980.17x 0.00x
2015-12-31 27.47x -0.01x 0.15x -3,091.00x 0.04x
2014-12-31 3.99x 0.08x 0.71x -5.38x -0.02x
2013-12-31 0.06x 0.00x 25.11x -13.63x 0.00x
2012-12-31 0.25x -0.24x 10.87x -7.10x -0.43x
2011-12-31 0.27x -0.16x 5.65x -8.18x -1.21x
2010-12-31 0.57x -0.26x 3.37x -12.78x -0.82x
2009-12-31 0.08x -0.20x 18.05x -17.95x -0.58x
2008-12-31 0.39x -0.57x 3.68x -18.57x -0.21x
2007-12-31 4.03x 8.17x 0.93x -1.96x -0.31x
2006-12-31 0.47x -1.45x 2.54x -0.70x 4.79x
2005-12-31 1.35x -1.83x 1.59x -4.58x -1.02x
2004-12-31 0.30x -2.11x 1.60x -4.33x -2.85x
2003-12-31 1.33x -2.43x 1.49x -4.24x -3.13x
2002-12-31 2.59x 30.01x 0.97x -6.81x -1.83x
2001-12-31 8.68x 1.55x 0.64x -5.39x -2.48x
2000-12-31 13.25x 0.90x 0.51x -17.71x -2.42x
1999-12-31 1.10x 0.01x 0.22x N/A -0.01x
1998-12-31 3.00x 0.06x 0.25x N/A -0.03x
1997-12-31 0.69x 0.30x 0.59x N/A -0.04x
1996-12-31 6.84x 0.04x 0.18x -258.07x -0.01x
1995-12-31 4.88x 0.00x 0.21x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ABEO.US!